Real-world effectiveness of elexacaftor/tezacaftor/ivacaftor on the burden of illness in adolescents and adults with cystic fibrosis.

Background: Elexacaftor/tezacaftor/ivacaftor (ELX/TEZ/IVA) has been shown to be safe and efficacious in people with cystic fibrosis (CF) aged ≥2 years. Here, we describe results from an observational study assessing change in burden of illness following initiating ELX/TEZ/IVA in real-world settings.

Methods: This US-based, multicenter, observational study used data from electronic medical records to evaluate real-world burden of illness before and after ELX/TEZ/IVA initiation in people with CF aged ≥12 years heterozygous for and a minimal function mutation (/MF) or an uncharacterized mutation.

Adsorptive removal of Ag/Au quantum dots onto covalent organic frameworks@magnetic zeolite@arabic gum hydrogel and their catalytic microwave-Fenton oxidative degradation of Rifampicin antibiotic.

Recent progress in nanotechnology via incorporation of small particle size as quantum dots (QDs) (1-10 nm) in many industrial activities and commercial products has led to significant undesired environmental impacts. Therefore, QDs removal from wastewater represents an interesting research topic with a lot of challenges for scientists and engineers nowadays. In this work, the coagulative removal of metal quantum dots as silver and gold from industrial water samples is explored.

Dysregulation of complement factor H in juvenile-onset systemic lupus erythematosus patients.

Objectives: This study aims to evaluate the expression pattern of factor H in peripheral blood and the frequency of factor H autoantibodies in plasma of juvenile-onset systemic lupus erythematosus (jSLE) patients compared to healthy controls.

Patients And Methods: Between March 2019 and October 2019, a total of 30 healthy individuals (3 males, 27 females; mean age: 26±7.4 years; range, 18 to 40 years) and 65 jSLE patients (age of onset ≤16 years) (2 males, 63 females; mean age: 23.

Association of microRNA-125a with the clinical features, disease activity and inflammatory cytokines of juvenile-onset lupus patients.

Background: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with marked variation in its clinical presentation. Juvenile-onset SLE (jSLE) exhibits an aggressive clinical phenotype and severe complications. Dysregulated expression of microRNAs (miRs) in immune cells from patients with SLE has been found.

Corrigendum: Dispersion and Stabilization of Exfoliated Graphene in Ionic Liquids.

[This corrects the article DOI: 10.3389/fchem.2019.